The Validity and Reliability of the Turkish Version of the BBAQ
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-35
SponsorIstanbul Medeniyet University
About this trial
The Barriers to Being Active Quiz (BBAQ) was originally developed in English to identify barriers to physical activity. This study aims to translate and cross-culturally adapt the BBAQ into Turkish (BBAQ-T) and evaluate its psychometric properties.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 18 years or older
Ability to read and write in Turkish
No visual or hearing impairments that would interfere with participation
Ability to follow simple instructions
Disqualifiers
Diagnosis of rheumatological conditions that may limit physical activity and are characterized by chronic inflammation and/or joint deformities (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, psoriatic arthritis)
Physical limitations due to neurological or orthopedic conditions (e.g., stroke, cerebral palsy, multiple sclerosis, limb amputation, or orthopedic surgery within the past six months)
History of psychiatric disorders that may impair cognitive functioning (e.g., schizophrenia, bipolar disorder, severe depression, attention deficit hyperactivity disorder)
Presence of any cognitive impairment
Trial population
The sample will consist of volunteer, healthy participants.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
210 Participants
are grouped into 1 trial groupGroup A: Healthy volunteers
Trial outcomes
Primary outcomes
1
Barriers to Being Active Quiz
The Barriers to Being Active Quiz (BBAQ) is a 21-item questionnaire originally developed by the Centers for Disease Control and Prevention (CDC) to identify perceived barriers to physical activity. Items are rated on a 4-point Likert-type scale ranging from 0 (very unlikely) to 3 (very likely). The scale includes seven sub-dimensions: lack of time, social influences, lack of energy, lack of willpower, fear of injury, lack of skills, and lack of resources. A subscale score of 5 or higher indicates a significant barrier in that domain. In this study, the BBAQ will be translated and cross-culturally adapted into Turkish following standardized guidelines.
Time frame
Baseline (First assessment)Secondary outcomes
1
Barriers to Being Active Quiz
The Barriers to Being Active Quiz (BBAQ) is a 21-item questionnaire originally developed by the Centers for Disease Control and Prevention (CDC) to identify perceived barriers to physical activity. Items are rated on a 4-point Likert-type scale ranging from 0 (very unlikely) to 3 (very likely). The scale includes seven sub-dimensions: lack of time, social influences, lack of energy, lack of willpower, fear of injury, lack of skills, and lack of resources. A subscale score of 5 or higher indicates a significant barrier in that domain. In this study, the BBAQ will be translated and cross-culturally adapted into Turkish following standardized guidelines
Time frame
Within a 5-to-7-day period after the first assessment (Second assessment)2
Self-Perceived Barriers for Physical Activity Questionnaire
This self-report instrument evaluates individuals' perceived obstacles to physical activity across personal, social, and environmental domains. It has been validated in Turkish and is used in this study to assess the convergent validity of the BBAQ-T. Participants rate the degree to which each item is a barrier to their physical activity.
Time frame
Baseline (First assessment)3
Short Form-12
The SF-12 is a widely used instrument that assesses health-related quality of life. It provides two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The Turkish version has been validated and will be used to further support the construct validity of the BBAQ-T by evaluating correlations with general health status
Time frame
Baseline (First assessment)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov